Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: ADR120S, Inc.

Market Cap 7.27B 45.03M 39.34M 36.39M 33.97M 63.77M 4.25B 64.23M 432M 168M 2.09B 169M 165M P/E 2024
62.8x
P/E 2025 -3.35x
Enterprise Value 9.66B 59.85M 52.29M 48.37M 45.15M 84.75M 5.66B 85.38M 575M 224M 2.78B 225M 220M EV / Sales 2024
6.46x
EV / Sales 2025 78.3x
Free-Float
21.25%
Yield 2024 *
-
Yield 2025 -
06-22 Colombia equities slide, peso up slightly as right-wing lawyer set to be next president RE
03-31 ADR120S, Inc. cancelled the acquisition of 71.51% stake in AthleteMed Corporation from EBISTRADE Inc. CI
25-10-28 ADR120S, Inc. share transfer agreement to acquire 71.51% stake in AthleteMed Corporation from EBISTRADE Inc. CI
24-09-24 Samty Hotel Management K.K. agreed to acquire Fractal Hospitality Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
24-03-12 Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
23-05-12 Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
21-12-26 Sakurajyuji Co., Ltd. signed an agreement to acquire approximately 1.60% stake in FRACTALE Corporation (TSE : 3750) from Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. for approximately ¥200 million. CI
21-05-14 FRACTALE Corporation canceled the acquisition of Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. CI
21-01-12 FRACTALE Corporation announced that it has received ¥12.675 million in funding from Japan International Partners LLC CI
20-12-27 FRACTALE Corporation announced that it expects to receive ¥12.675 million in funding from Japan International Partners LLC CI
20-07-02 FRACTALE Corporation acquired 91% stake in Alegrox Hotel Management Co., Ltd from Shinji Ezure and others for ¥21.2 million. CI
20-05-14 FRACTALE Corporation agreed to acquire the remaining 43.63% stake in Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. for ¥2.1 billion. CI
20-02-24 Osaka Mokuzai Sougo Ichiba Co., Ltd. cancelled the acquisition of Ikeda Fudosan Co., Ltd. from FRACTALE Corporation. CI
1 week-0.76%
Current month-1.88%
1 month-2.24%
3 months-11.60%
6 months-5.19%
Current year-6.55%
1 week 785
Extreme 785
800
1 month 782
Extreme 782
813
Current year 780
Extreme 780
890
1 year 737
Extreme 737
990
3 years 642
Extreme 642
1,284
5 years 642
Extreme 642
1,750
10 years 184.4
Extreme 184.4
1,841
Manager TitleAgeSince
President 69 2023-05-31
Investor Relations Contact 54 2019-10-31
Director TitleAgeSince
Director/Board Member 73 2024-12-31
Director/Board Member 56 2010-09-30
Chairman 69 2024-05-31
Date Insider Type Main position Quantity % Market Cap.
25-04-08Free 130,100 1.4570%
25-04-08Free 321,100 3.5960%
25-03-05Buy

Chairman

214,300 2.3999%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.76%+6.51%-24.45% 43.74M
-1.22%-3.14%-2.94%+70.45% 38.52B
+0.60%-9.47%-16.67%-0.53% 17.18B
-0.82%-1.14%+23.64%+98.81% 13.79B
-0.93%-8.25%+2.07%+1.13% 11.31B
-1.56%-2.33%-0.79%-25.22% 9.9B
-6.25%-6.79%-54.28%-36.14% 7.37B
-4.07%-7.99%-22.10%-1.79% 6.25B
-2.35%-4.75%-28.44%+2.61% 4.68B
+1.63%-0.57%+0.46%+44.30% 4.58B
Average -1.50%-4.35%-9.25%+12.92% 11.36B
Weighted average by Cap. -1.31%-4.67%-6.39%+33.16%

Financials

2024 2025
Net sales 1.56B 9.66M 8.45M 7.81M 7.29M 13.69M 913M 13.79M 92.83M 36.12M 449M 36.29M 35.5M 122M 756K 660K 611K 570K 1.07M 71.43M 1.08M 7.26M 2.82M 35.12M 2.84M 2.78M
Net income 138M 855K 747K 691K 645K 1.21M 80.8M 1.22M 8.21M 3.2M 39.72M 3.21M 3.14M -2.14B -13.26M -11.59M -10.72M -10M -18.78M -1.25B -18.91M -127M -49.55M -616M -49.78M -48.7M
Net Debt 1.43B 8.88M 7.76M 7.18M 6.7M 12.57M 839M 12.67M 85.27M 33.18M 412M 33.33M 32.61M 2.39B 14.82M 12.95M 11.98M 11.18M 20.99M 1.4B 21.14M 142M 55.38M 689M 55.64M 54.43M
Logo ADR120S, Inc.
ADR120S Inc, formerly Cytori Cell Research Institute Inc, is a Japan-based company mainly engaged in investing in medical assets, buying and selling real estate, investing in real estate business projects, and managing its real estate holdings. The Company operates its business through two segments. The Medical Business segment is engaged in investments in regenerative medicine and other businesses. The Real Assets business segment is mainly engaged in real estate sales and purchase, investment in real estate business projects, and hotel business.
Employees
10
Date Price Change Volume
26-06-22 785.00 ¥ 0.00% 1,800
26-06-22 785.00 ¥ -0.63% 2,000
26-06-19 790.00 ¥ -0.13% 4,300
26-06-18 791.00 ¥ -0.88% 6,800
26-06-17 798.00 ¥ +0.88% 2,000

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3750 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!